Concepedia

Natalie Memoli

NM

Statistics

Publications

5

Citations

1K

H-Index

5

Active since

2002

Affiliations

Dartmouth–Hitchcock Medical Center(Current)

Immunovaccine (Canada)

Dartmouth College

Natalie Memoli is an author at Dartmouth–Hitchcock Medical Center specializing in oncology, pharmacology, and medicine.

Publications per year

2002–2004

5

Publications

5

Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

Vincent A. Miller, Mark G. Kris, Jyoti D. Patel et al. · Journal of Clinical Oncology · 2004 · 746 citations

, , +16

Evidence for the epidermal growth factor receptor as a target for lung cancer prevention.

Fulvio Lonardo, Konstantin H. Dragnev, Sarah J. Freemantle et al. · PubMed · 2002 · 98 citations

, , +14

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers

W. Jeffrey Petty, Konstantin H. Dragnev, Vincent A. Memoli et al. · Clinical Cancer Research · 2004 · 96 citations · Full text

, , +17

Microarray Analyses Uncover UBE1L as a Candidate Target Gene for Lung Cancer Chemoprevention

Ian Pitha, W. Jeffrey Petty, Qing Feng et al. · Cancer Research · 2004 · 48 citations

, , +15

O-188 Encouraging activity and durable responses demonstrated by the epithelial growth factor receptor-tyrosine kinase inhibitor, Erlotinib (Tarceva TM, OSI774), in patients with advanced bronchioloalveolar (BAC) cell carcinoma

Jyoti D. Patel, Vincent A. Miller, Mark G. Kris et al. · Lung Cancer · 2003 · 22 citations

, , +10

1–5 of 5